Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

B. Braun acquires exclusive rights to market, manufacture, license and support CytoCare

B.Braun Melsungen : 28 January, 2008  (New Product)
B. Braun and Health-Robotics has signed a long-term and exclusive strategic agreement for B. Braun to exclusively utilise Health-Robotics IV Admixture Automation Solutions worldwide within the oncology, pain management, antibiotics, radio pharmaca, and all other IV therapy and clinical nutrition.
B. Braun has also immediately acquired from Health-Robotics the long-term, exclusive rights to manufacture, assemble, market, license, provide installation and integration services and support for the CytoCare Robot in Europe, Latin America, Africa, Oceania, and most of Asia.

With its CytoCare Robot, Health-Robotics has developed the first totally automated system for safe preparation of patient-specific hazardous IV doses.

“CytoCare constitutes an advance for patient and clinician’s safety,” said Werner Rainer, general manager, Health-Robotics. “This strategic agreement with B. Braun combines state-of-the-art technologies to achieve the accuracy and sterility that providers require for automating patient-specific IV admixture preparations with B. Braun’s world-class organization. The resulting technology is the only totally automated system for handling hazardous IV admixtures available in the market. In addition, CytoCare is the only IV Admixtures Preparation Automated solution that enables global health care providers with flexibility to utilise a wide range of final IV containers”.

“Everyone within our company and customer base is extremely proud of being selected by an organization of the calibre and outstanding reputation of B. Braun”.

This agreement tightly fits with B. Braun’s mission of becoming the customer´s first choice for infusion therapy and providing world-class technology for IV pharmacy operations.

Markus Strotmann, senior vice president of strategic marketing for B. Braun Melsungen noted, 'B. Braun is very pleased to reach a long-term strategic agreement with Health-Robotics. We have closely worked with Health-Robotics for approximately one year market-testing the concept of CytoCare and conducting technical due diligence. We hope that this strategic collaboration with Health-Robotics grows over time in delivering improved Patient safety solutions to B. Braun’s customers in areas beyond oncology and to continue the integration work we initiated last year with our industry-leading Ecoflac and EasyPump solutions. Such an end-to-end solution for IV Therapy will also help drive down the complexity, medication errors, initial cost and daily operating expenses - which are key issues for healthcare organizations”.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   Â© 2012 ProHealthServiceZone.com
Netgains Logo